January 26, 2021 Boston, MA: Putnam Associates, part of Ashfield Advisory, announces that PHMR Limited, a global consulting firm specializing in market access and health economics outcomes research (HEOR), will join Putnam’s Value, Pricing and Access practice area. PHMR specializes in health economics, real world evidence, patient reported outcomes, health technology assessments and other HEOR activities
read moreIn 2019, Putnam formed a select panel of cell and gene therapy (CGT) experts to meet our clients’ growing demand for CGT strategy and commercialization support. By engaging with our expert panel, Putnam is at the leading edge of this rapidly evolving space, delivering to our CGT-focused clients unparalleled insight into clinical decision-making, product on-boarding
read moreNovember 23, 2020 Boston, MA Putnam Associates has been named one of the Top Places to Work in Massachusetts in the 13th annual employee-based survey project from The Boston Globe. The Top Places to Work 2020 issue publishes online at Globe.com/TopPlaces on the night of November 19 and in Globe Magazine on November 22. Top Places
read moreJuly 10, 2020 – Putnam is honored to be a member of the MIT Solve community for the fourth year in a row! Putnam teams convened virtually today to contribute to the initial screening of proposals by assessing and scoring submissions. All told, our team will have reviewed and provided feedback on 150 submissions, helping
read moreEric Auger, Partner, was a recent speaker at the European Society of Gene & Cell Therapy Annual Congress held in collaboration with ISSCR and SFTCG, in Lausanne, Switzerland on October 16th-19th. The Congress brings together scientists, commercial leaders, business development professionals and investors
read moreA study released today at the BIO International Convention shows increased employment within the U.S. bioscience industry for the last four consecutive years. The report also shows impressive bioscience industry strength and resilience, with employment growth of nearly 10 percent since 2001. Among technology sectors the bioscience industry has been a leading performer over this period.
read morePutnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.
